| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 9.67e-11 | 37 | 132 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.22e-10 | 38 | 132 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 5.81e-07 | 11 | 132 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.73e-06 | 14 | 132 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | zinc ion binding | TRIM72 ERVK-6 ZDBF2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 NR1D1 RBM20 USP20 P2RX7 AOPEP ERVK-8 ADAMTS15 ZNF638 ERVK-19 NEIL3 ERVK-24 RABGGTA | 6.37e-06 | 891 | 132 | 19 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.00e-05 | 21 | 132 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.02e-04 | 37 | 132 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | transition metal ion binding | TRIM72 TBXAS1 ERVK-6 ZDBF2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 NR1D1 RBM20 USP20 P2RX7 AOPEP ERVK-8 ADAMTS15 ZNF638 ERVK-19 NEIL3 ERVK-24 RABGGTA | 1.06e-04 | 1189 | 132 | 20 | GO:0046914 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 HMCES USP20 USP26 AOPEP ERVK-8 ADAMTS15 PRSS42P ERVK-19 ERVK-24 | 1.11e-04 | 654 | 132 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.13e-04 | 38 | 132 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 USP20 ERVK-8 ADAMTS15 PRSS42P ERVK-19 ERVK-24 | 1.36e-04 | 430 | 132 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.40e-04 | 46 | 132 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.58e-04 | 262 | 132 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 4.28e-04 | 5 | 132 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | extracellularly ATP-gated monoatomic cation channel activity | 8.91e-04 | 7 | 132 | 2 | GO:0004931 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A CACNA1C CACNA2D1 KCNH8 TRPM7 TPTE2 KCNAB2 GRID2 P2RX5 P2RX7 | 9.60e-04 | 459 | 132 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.34e-03 | 182 | 132 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.42e-03 | 184 | 132 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | ATP-gated ion channel activity | 1.51e-03 | 9 | 132 | 2 | GO:0035381 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.72e-03 | 334 | 132 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.87e-03 | 79 | 132 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.04e-03 | 343 | 132 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SELP MYH9 VWF OBSCN NLGN1 THBS4 TENM4 MYPN CTNNA3 HCFC1 RPL7A | 2.12e-03 | 599 | 132 | 11 | GO:0050839 |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 VWF OBSCN ERVK-7 ERVK-21 ERVK-9 ERVK-10 THBS4 HMCN1 ERVK-8 ERVK-19 ERVK-24 KRTAP27-1 RPL7A | 2.32e-03 | 891 | 132 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | channel activity | CACNA1A CACNA1C CACNA2D1 KCNH8 TRPM7 TPTE2 KCNAB2 GRID2 P2RX5 P2RX7 | 2.59e-03 | 525 | 132 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A CACNA1C CACNA2D1 KCNH8 TRPM7 TPTE2 KCNAB2 GRID2 P2RX5 P2RX7 | 2.62e-03 | 526 | 132 | 10 | GO:0022803 |
| GeneOntologyBiologicalProcess | DNA integration | 1.16e-06 | 13 | 134 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.35e-06 | 85 | 134 | 7 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.35e-06 | 85 | 134 | 7 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.85e-06 | 89 | 134 | 7 | GO:0006949 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 5.58e-05 | 63 | 134 | 5 | GO:0007157 | |
| Domain | Gonadal | 4.59e-05 | 2 | 127 | 2 | IPR010849 | |
| Domain | DGCR6 | 4.59e-05 | 2 | 127 | 2 | PF07324 | |
| Domain | TIL_dom | 1.06e-04 | 14 | 127 | 3 | IPR002919 | |
| Domain | Pellino | 1.37e-04 | 3 | 127 | 2 | PF04710 | |
| Domain | Pellino_fam | 1.37e-04 | 3 | 127 | 2 | IPR006800 | |
| Domain | Neural_cell_adh | 2.73e-04 | 4 | 127 | 2 | IPR009138 | |
| Domain | FN3 | 2.75e-04 | 185 | 127 | 7 | SM00060 | |
| Domain | FN3 | 4.27e-04 | 199 | 127 | 7 | PS50853 | |
| Domain | FN3_dom | 5.72e-04 | 209 | 127 | 7 | IPR003961 | |
| Domain | DDHD | 6.76e-04 | 6 | 127 | 2 | PF02862 | |
| Domain | DDHD | 6.76e-04 | 6 | 127 | 2 | PS51043 | |
| Domain | DDHD_dom | 6.76e-04 | 6 | 127 | 2 | IPR004177 | |
| Domain | DDHD | 6.76e-04 | 6 | 127 | 2 | SM01127 | |
| Domain | P2X_receptor | 9.42e-04 | 7 | 127 | 2 | PF00864 | |
| Domain | P2X_purnocptor | 9.42e-04 | 7 | 127 | 2 | IPR001429 | |
| Domain | - | 9.42e-04 | 7 | 127 | 2 | 2.60.490.10 | |
| Domain | Ca_chan_IQ | 9.42e-04 | 7 | 127 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 9.42e-04 | 7 | 127 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 9.42e-04 | 7 | 127 | 2 | IPR014873 | |
| Domain | GPHH | 9.42e-04 | 7 | 127 | 2 | PF16905 | |
| Domain | GPHH_dom | 9.42e-04 | 7 | 127 | 2 | IPR031649 | |
| Domain | P2X_RECEPTOR | 9.42e-04 | 7 | 127 | 2 | PS01212 | |
| Domain | P2X_extracellular_dom | 9.42e-04 | 7 | 127 | 2 | IPR027309 | |
| Domain | Ion_trans_dom | 1.09e-03 | 114 | 127 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.09e-03 | 114 | 127 | 5 | PF00520 | |
| Domain | SPARC/Testican_Ca-bd-dom | 1.25e-03 | 8 | 127 | 2 | IPR019577 | |
| Domain | SPARC_Ca_bdg | 1.25e-03 | 8 | 127 | 2 | PF10591 | |
| Domain | HEAT_REPEAT | 1.32e-03 | 70 | 127 | 4 | PS50077 | |
| Domain | - | 1.62e-03 | 74 | 127 | 4 | 3.40.50.410 | |
| Domain | - | IL12RB2 OBSCN LRRN3 CSF2RA LINGO1 HMCN1 MYPN PKHD1 CD58 ROBO2 LRRN4 HCFC1 | 1.89e-03 | 663 | 127 | 12 | 2.60.40.10 |
| Domain | Ig_I-set | 1.91e-03 | 190 | 127 | 6 | IPR013098 | |
| Domain | I-set | 1.91e-03 | 190 | 127 | 6 | PF07679 | |
| Domain | VDCCAlpha1 | 1.99e-03 | 10 | 127 | 2 | IPR002077 | |
| Domain | VWFA | 2.37e-03 | 82 | 127 | 4 | PS50234 | |
| Domain | IL6Ra-bind | 2.42e-03 | 11 | 127 | 2 | PF09240 | |
| Domain | TypeI_recpt_CBD | 2.42e-03 | 11 | 127 | 2 | IPR015321 | |
| Domain | VWA | 2.59e-03 | 84 | 127 | 4 | SM00327 | |
| Domain | C8 | 2.90e-03 | 12 | 127 | 2 | PF08742 | |
| Domain | TIL | 2.90e-03 | 12 | 127 | 2 | PF01826 | |
| Domain | Znf_C2H2_matrin | 2.90e-03 | 12 | 127 | 2 | IPR000690 | |
| Domain | Ig-like_fold | IL12RB2 OBSCN LRRN3 CSF2RA LINGO1 HMCN1 MYPN PKHD1 CD58 ROBO2 LRRN4 HCFC1 | 3.16e-03 | 706 | 127 | 12 | IPR013783 |
| Domain | Carboxylesterase_B_CS | 3.41e-03 | 13 | 127 | 2 | IPR019819 | |
| Domain | Unchr_dom_Cys-rich | 3.41e-03 | 13 | 127 | 2 | IPR014853 | |
| Domain | C8 | 3.41e-03 | 13 | 127 | 2 | SM00832 | |
| Domain | LRR_1 | 3.87e-03 | 219 | 127 | 6 | PF00560 | |
| Domain | CARBOXYLESTERASE_B_2 | 3.96e-03 | 14 | 127 | 2 | PS00941 | |
| Domain | COesterase | 3.96e-03 | 14 | 127 | 2 | PF00135 | |
| Domain | CarbesteraseB | 3.96e-03 | 14 | 127 | 2 | IPR002018 | |
| Domain | IBN_N | 4.55e-03 | 15 | 127 | 2 | PF03810 | |
| Domain | VWF_A | 4.67e-03 | 99 | 127 | 4 | IPR002035 | |
| Domain | fn3 | 5.02e-03 | 162 | 127 | 5 | PF00041 | |
| Domain | VWF_type-D | 5.17e-03 | 16 | 127 | 2 | IPR001846 | |
| Domain | IBN_N | 5.17e-03 | 16 | 127 | 2 | SM00913 | |
| Domain | VWFD | 5.17e-03 | 16 | 127 | 2 | PS51233 | |
| Domain | VWD | 5.17e-03 | 16 | 127 | 2 | SM00216 | |
| Domain | VWD | 5.17e-03 | 16 | 127 | 2 | PF00094 | |
| Domain | IGc2 | 5.44e-03 | 235 | 127 | 6 | SM00408 | |
| Domain | Ig_sub2 | 5.44e-03 | 235 | 127 | 6 | IPR003598 | |
| Domain | - | 5.84e-03 | 17 | 127 | 2 | 4.10.800.10 | |
| Domain | Thyroglobulin_1 | 5.84e-03 | 17 | 127 | 2 | IPR000716 | |
| Domain | THYROGLOBULIN_1_1 | 5.84e-03 | 17 | 127 | 2 | PS00484 | |
| Domain | Importin-beta_N | 5.84e-03 | 17 | 127 | 2 | IPR001494 | |
| Domain | TY | 5.84e-03 | 17 | 127 | 2 | SM00211 | |
| Domain | THYROGLOBULIN_1_2 | 5.84e-03 | 17 | 127 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 5.84e-03 | 17 | 127 | 2 | PF00086 | |
| Domain | ZF_MATRIN | 6.54e-03 | 18 | 127 | 2 | PS50171 | |
| Domain | CTCK_1 | 6.54e-03 | 18 | 127 | 2 | PS01185 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 2.17e-10 | 4 | 135 | 4 | 10469592 | |
| Pubmed | 6.34e-10 | 12 | 135 | 5 | 14557543 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.08e-09 | 5 | 135 | 4 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.51e-09 | 94 | 135 | 8 | 21542922 | |
| Pubmed | CACNA1A CACNA2D1 MYH9 TRAF3IP1 NUMBL IQSEC2 KCNAB2 TRIOBP SPATA20 SIK3 EHD3 MDN1 P2RX7 TAX1BP1 SEC23IP PLCB1 NIPBL PROX1 | 3.96e-08 | 963 | 135 | 18 | 28671696 | |
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 7983737 | ||
| Pubmed | 6.37e-07 | 18 | 135 | 4 | 18664271 | ||
| Pubmed | 1.13e-06 | 6 | 135 | 3 | 15063128 | ||
| Pubmed | 6.73e-06 | 10 | 135 | 3 | 12970426 | ||
| Pubmed | Nucleolar protein trafficking in response to HIV-1 Tat: rewiring the nucleolus. | 1.29e-05 | 77 | 135 | 5 | 23166591 | |
| Pubmed | Elementary mechanisms producing facilitation of Cav2.1 (P/Q-type) channels. | 1.50e-05 | 2 | 135 | 2 | 17438119 | |
| Pubmed | Inhibition of the P2X7-PANX1 complex suppresses spreading depolarization and neuroinflammation. | 1.50e-05 | 2 | 135 | 2 | 28430869 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20007545 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 27418245 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 32540996 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 9605865 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 18802014 | ||
| Pubmed | Alpha T-catenin (CTNNA3): a gene in the hand is worth two in the nest. | 1.50e-05 | 2 | 135 | 2 | 21598020 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 38981023 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21628556 | ||
| Pubmed | L-type calcium channels contribute to the tottering mouse dystonic episodes. | 1.50e-05 | 2 | 135 | 2 | 9882694 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22832905 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.50e-05 | 2 | 135 | 2 | 9460924 | |
| Pubmed | The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis. | 1.50e-05 | 2 | 135 | 2 | 29565179 | |
| Pubmed | Altered Actions of Memantine and NMDA-Induced Currents in a New Grid2-Deleted Mouse Line. | 1.50e-05 | 2 | 135 | 2 | 25513882 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 15821931 | ||
| Pubmed | A Selectivity Filter Gate Controls Voltage-Gated Calcium Channel Calcium-Dependent Inactivation. | 1.50e-05 | 2 | 135 | 2 | 30733149 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 25238857 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11157784 | ||
| Pubmed | Megalin (gp330): a putative endocytic receptor for thyroglobulin (Tg). | 1.50e-05 | 2 | 135 | 2 | 9492085 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20716766 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26962963 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 38355315 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 14630802 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.80e-05 | 139 | 135 | 6 | 16985003 | |
| Pubmed | 2.52e-05 | 15 | 135 | 3 | 20188150 | ||
| Pubmed | 2.52e-05 | 15 | 135 | 3 | 24453333 | ||
| Pubmed | 2.52e-05 | 15 | 135 | 3 | 36305765 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPC2 MYH9 TRMT112 GPATCH1 WWTR1 DCLRE1B AURKA PPIG MDN1 ZNF638 CKAP4 NIPBL HCFC1 RPL7A ILVBL NOL8 | 4.44e-05 | 1294 | 135 | 16 | 30804502 |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 28427417 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 18394644 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 26216687 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17849054 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 29077161 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17224476 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 9971820 | ||
| Pubmed | Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair. | 4.48e-05 | 3 | 135 | 2 | 22253476 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17996853 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 28232180 | ||
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 4.48e-05 | 3 | 135 | 2 | 29208674 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 27302665 | ||
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 4.48e-05 | 3 | 135 | 2 | 26507659 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 25390649 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 19767732 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17275499 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 23338940 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 29581247 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 22100896 | ||
| Pubmed | Endothelial cell markers in patients with pseudoexfoliation syndrome. | 4.48e-05 | 3 | 135 | 2 | 22593709 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 12526796 | ||
| Pubmed | Age and gender-dependent alternative splicing of P/Q-type calcium channel EF-hand. | 4.48e-05 | 3 | 135 | 2 | 17291689 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 20817017 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 19106618 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 10516026 | ||
| Pubmed | Expression of P-selectin, von Willebrand and endothelin-1 after carotid artery stenting. | 4.48e-05 | 3 | 135 | 2 | 21638248 | |
| Pubmed | Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia. | 4.48e-05 | 3 | 135 | 2 | 29387948 | |
| Pubmed | Loss of calcium channels in the cerebellum of the ataxic and epileptic stargazer mutant mouse. | 4.48e-05 | 3 | 135 | 2 | 19422811 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 27943541 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 24661878 | ||
| Pubmed | Central Mechanisms Mediating Thrombospondin-4-induced Pain States. | 4.48e-05 | 3 | 135 | 2 | 27129212 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 29166599 | ||
| Pubmed | EMC chaperone-CaV structure reveals an ion channel assembly intermediate. | 4.48e-05 | 3 | 135 | 2 | 37196677 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 21642543 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 12036879 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 24329154 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PITPNM2 CACNA1C KCNH8 NUMBL OBSCN HIPK2 TRIOBP WDR27 ITPK1 EHD3 RANBP17 EXD3 AOPEP SEL1L3 ZNF638 NLRC5 NLK | 6.77e-05 | 1489 | 135 | 17 | 28611215 |
| Pubmed | 7.23e-05 | 21 | 135 | 3 | 20227257 | ||
| Pubmed | 7.23e-05 | 21 | 135 | 3 | 20708005 | ||
| Pubmed | Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease. | 7.23e-05 | 21 | 135 | 3 | 27591083 | |
| Pubmed | 8.34e-05 | 22 | 135 | 3 | 12768436 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 22279216 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 8910533 | ||
| Pubmed | TRPM7, a novel regulator of actomyosin contractility and cell adhesion. | 8.93e-05 | 4 | 135 | 2 | 16407977 | |
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 12787128 | ||
| Pubmed | Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. | 8.93e-05 | 4 | 135 | 2 | 15082531 | |
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 19010321 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 20226536 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 8.93e-05 | 4 | 135 | 2 | 32616470 | |
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 15728831 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 11071623 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 15956287 | ||
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 16884718 | ||
| Pubmed | Pellino proteins contain a cryptic FHA domain that mediates interaction with phosphorylated IRAK1. | 8.93e-05 | 4 | 135 | 2 | 19081057 | |
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 8.93e-05 | 4 | 135 | 2 | 21788606 | |
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 20678249 | ||
| Pubmed | Dependence of parvalbumin expression on Purkinje cell input in the deep cerebellar nuclei. | 8.93e-05 | 4 | 135 | 2 | 9514513 | |
| Pubmed | Factors associated with early platelet activation in obese children. | 8.93e-05 | 4 | 135 | 2 | 24415745 | |
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 8.93e-05 | 4 | 135 | 2 | 15953418 | |
| Pubmed | 8.93e-05 | 4 | 135 | 2 | 12880424 | ||
| GeneFamily | Pellino E3 ubiquitin protein ligases | 6.69e-05 | 3 | 86 | 2 | 676 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.19e-04 | 161 | 86 | 6 | 593 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.50e-04 | 26 | 86 | 3 | 253 | |
| GeneFamily | Purinergic receptors P2X | 4.62e-04 | 7 | 86 | 2 | 214 | |
| GeneFamily | Fibronectin type III domain containing | 9.97e-04 | 160 | 86 | 5 | 555 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | CACNA1C CACNA2D1 DENND4A VWF NUMBL TRPM7 RBL2 PELI3 WWTR1 NLGN1 PPIG TENM4 CSF2RA LINGO1 HMCN1 AOPEP MRC2 ADAMTS15 ROBO2 SGCE NEIL3 TMEM26 PROX1 | 2.89e-07 | 1166 | 125 | 23 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | TBXAS1 CACNA1A CACNA1C CACNA2D1 VWF NUMBL RBL2 GPATCH1 IQSEC2 TRIOBP WWTR1 NLGN1 SIK3 TENM4 CSF2RA LINGO1 HMCN1 AOPEP MRC2 IPO13 ROBO2 NEIL3 TMEM26 | 5.37e-07 | 1208 | 125 | 23 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | CACNA1C CACNA2D1 DENND4A VWF NUMBL RBL2 TRIOBP LRRTM3 NLGN1 SIK3 TENM4 LINGO1 HMCN1 AOPEP MRC2 ADAMTS15 PLCB1 IPO13 ROBO2 NEIL3 TMEM26 | 3.38e-06 | 1148 | 125 | 21 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CACNA1A EPC2 IL12RB2 NUMBL TRPM7 CHCHD5 HIPK2 PEX1 TRIOBP PELI1 ZDBF2 SIK3 RANBP17 PPIG NOXO1 GSTCD SGCE MMS19 NIPBL SLFNL1 NLK PROX1 | 1.52e-05 | 1370 | 125 | 22 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | CACNA1A EPC2 DENND4A NUMBL RBL2 HIPK2 PELI1 WWTR1 ZDBF2 NLGN1 RANBP17 CSF2RA GSTCD SGCE NLK PROX1 | 7.14e-05 | 893 | 125 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | CACNA1C CACNA2D1 MYH9 OBSCN LRRTM3 RBM20 AOPEP MYPN CTNNA3 DDX60L | 1.18e-10 | 182 | 126 | 10 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | CACNA1C CACNA2D1 OBSCN LRRTM3 NLGN1 RBM20 LINGO1 MYPN CTNNA3 FYB2 | 1.31e-10 | 184 | 126 | 10 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | CACNA1C MYH9 OBSCN LRRTM3 NLGN1 RBM20 AOPEP MYPN CTNNA3 FYB2 | 1.70e-10 | 189 | 126 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | CACNA1C MYH9 OBSCN LRRTM3 SIK3 RBM20 AOPEP MYPN CTNNA3 DDX60L | 1.79e-10 | 190 | 126 | 10 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.01e-09 | 185 | 126 | 9 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 4.17e-09 | 192 | 126 | 9 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.96e-08 | 176 | 126 | 8 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.83e-08 | 185 | 126 | 8 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.88e-08 | 189 | 126 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.16e-08 | 190 | 126 | 8 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.16e-08 | 190 | 126 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.46e-08 | 191 | 126 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.46e-08 | 191 | 126 | 8 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.08e-08 | 193 | 126 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.62e-07 | 170 | 126 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 5.62e-07 | 170 | 126 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.57e-07 | 174 | 126 | 7 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-07 | 178 | 126 | 7 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.57e-07 | 181 | 126 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 8.57e-07 | 181 | 126 | 7 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 184 | 126 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.56e-07 | 184 | 126 | 7 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 184 | 126 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 184 | 126 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.56e-07 | 184 | 126 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.91e-07 | 185 | 126 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-06 | 187 | 126 | 7 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.10e-06 | 188 | 126 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.10e-06 | 188 | 126 | 7 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 189 | 126 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.18e-06 | 190 | 126 | 7 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-06 | 190 | 126 | 7 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.18e-06 | 190 | 126 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.23e-06 | 191 | 126 | 7 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.27e-06 | 192 | 126 | 7 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 192 | 126 | 7 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 192 | 126 | 7 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.27e-06 | 192 | 126 | 7 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-06 | 193 | 126 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.33e-06 | 122 | 126 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 194 | 126 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.36e-06 | 194 | 126 | 7 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.41e-06 | 195 | 126 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.41e-06 | 195 | 126 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 1.61e-06 | 199 | 126 | 7 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | RSV-Healthy-6|Healthy / Virus stimulation, Condition and Cluster | 7.34e-06 | 164 | 126 | 6 | 1b9c5a6dc4e09b90f92e98b81a5ee620f8479cc7 | |
| ToppCell | RSV-Healthy-6|RSV / Virus stimulation, Condition and Cluster | 7.34e-06 | 164 | 126 | 6 | ab312b8c2f828ea7331f2a340c4df81587a23b5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 164 | 126 | 6 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.64e-06 | 172 | 126 | 6 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 175 | 126 | 6 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 176 | 126 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 177 | 126 | 6 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 178 | 126 | 6 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 179 | 126 | 6 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 1.23e-05 | 105 | 126 | 5 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-05 | 180 | 126 | 6 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.25e-05 | 180 | 126 | 6 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 181 | 126 | 6 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 181 | 126 | 6 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-05 | 182 | 126 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 183 | 126 | 6 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.37e-05 | 183 | 126 | 6 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-05 | 183 | 126 | 6 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 184 | 126 | 6 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 185 | 126 | 6 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.55e-05 | 187 | 126 | 6 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 187 | 126 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.55e-05 | 187 | 126 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.60e-05 | 188 | 126 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-05 | 188 | 126 | 6 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-05 | 188 | 126 | 6 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.60e-05 | 188 | 126 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.65e-05 | 189 | 126 | 6 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 189 | 126 | 6 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.65e-05 | 189 | 126 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 189 | 126 | 6 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 190 | 126 | 6 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-05 | 190 | 126 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.70e-05 | 190 | 126 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.70e-05 | 190 | 126 | 6 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-05 | 190 | 126 | 6 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.75e-05 | 191 | 126 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-05 | 192 | 126 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-05 | 192 | 126 | 6 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 192 | 126 | 6 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 192 | 126 | 6 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 192 | 126 | 6 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 192 | 126 | 6 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 193 | 126 | 6 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.85e-05 | 193 | 126 | 6 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 193 | 126 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 193 | 126 | 6 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.85e-05 | 193 | 126 | 6 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 193 | 126 | 6 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 193 | 126 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 193 | 126 | 6 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | droplet-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 193 | 126 | 6 | cba070019db30604ebddb610eedf92e48221ac58 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.85e-05 | 193 | 126 | 6 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 193 | 126 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-05 | 194 | 126 | 6 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| Disease | triacylglycerol 52:5 measurement | 1.45e-05 | 35 | 125 | 4 | EFO_0010417 | |
| Disease | suicide behaviour | 3.65e-05 | 44 | 125 | 4 | EFO_0007623 | |
| Disease | serum gamma-glutamyl transferase measurement | PLB1 TRPM7 GPATCH1 TRIOBP GON4L RASIP1 TENM4 P2RX7 PKHD1 C3 SIPA1L2 MED13 PROX1 | 1.39e-04 | 914 | 125 | 13 | EFO_0004532 |
| Disease | Cardiac Arrhythmia | 1.59e-04 | 25 | 125 | 3 | C0003811 | |
| Disease | suicide ideation measurement | 1.77e-04 | 5 | 125 | 2 | EFO_0007619 | |
| Disease | proline measurement, amino acid measurement | 1.77e-04 | 5 | 125 | 2 | EFO_0005134, EFO_0009773 | |
| Disease | brain cancer (implicated_via_orthology) | 1.80e-04 | 26 | 125 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | essential tremor | 2.91e-04 | 136 | 125 | 5 | EFO_0003108 | |
| Disease | Adenine measurement | 3.69e-04 | 7 | 125 | 2 | EFO_0021573 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 6.12e-04 | 160 | 125 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | 2-hydroxyglutaric acid measurement | 6.29e-04 | 9 | 125 | 2 | EFO_0010446 | |
| Disease | membranous glomerulonephritis (implicated_via_orthology) | 6.29e-04 | 9 | 125 | 2 | DOID:10976 (implicated_via_orthology) | |
| Disease | acute necrotizing pancreatitis (implicated_via_orthology) | 7.84e-04 | 10 | 125 | 2 | DOID:0080998 (implicated_via_orthology) | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 7.84e-04 | 10 | 125 | 2 | EFO_0008321 | |
| Disease | Shortened QT interval | 9.55e-04 | 11 | 125 | 2 | C0151879 | |
| Disease | brain volume measurement | SELP CACNA1A NUMBL TPTE2 GPATCH1 TRIOBP GON4L PKHD1 ADAMTS15 | 1.00e-03 | 595 | 125 | 9 | EFO_0006930 |
| Disease | autoimmune thyroiditis (is_implicated_in) | 1.14e-03 | 12 | 125 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | progression free survival, urinary bladder cancer | 1.14e-03 | 12 | 125 | 2 | EFO_0004920, MONDO_0001187 | |
| Disease | response to simvastatin, total cholesterol change measurement, response to fenofibrate | 1.33e-03 | 51 | 125 | 3 | EFO_0007806, GO_1901557, GO_1903491 | |
| Disease | pallidum volume change measurement | 1.35e-03 | 13 | 125 | 2 | EFO_0021494 | |
| Disease | Depressive disorder | 1.49e-03 | 289 | 125 | 6 | C0011581 | |
| Disease | non-alcoholic fatty liver disease, cirrhosis of liver | 1.49e-03 | 53 | 125 | 3 | EFO_0001422, EFO_0003095 | |
| Disease | late-onset Alzheimers disease | 1.57e-03 | 292 | 125 | 6 | EFO_1001870 | |
| Disease | response to methotrexate, aspartate aminotransferase measurement | 1.57e-03 | 14 | 125 | 2 | EFO_0004736, GO_0031427 | |
| Disease | Majewski Syndrome | 1.57e-03 | 14 | 125 | 2 | C0024507 | |
| Disease | retinal vasculature measurement | 1.66e-03 | 517 | 125 | 8 | EFO_0010554 | |
| Disease | triacylglycerol 52:2 measurement | 1.66e-03 | 55 | 125 | 3 | EFO_0010414 | |
| Disease | gamma-glutamylphenylalanine measurement | 1.80e-03 | 15 | 125 | 2 | EFO_0021142 | |
| Disease | Proteinuria | 1.80e-03 | 15 | 125 | 2 | HP_0000093 | |
| Disease | Hypertrophic Cardiomyopathy | 1.84e-03 | 57 | 125 | 3 | C0007194 | |
| Disease | optic disc size measurement | 1.84e-03 | 205 | 125 | 5 | EFO_0004832 | |
| Disease | adverse effect, response to xenobiotic stimulus | 2.03e-03 | 59 | 125 | 3 | EFO_0009658, GO_0009410 | |
| Disease | neutrophil count | SELP CACNA1A MTMR12 DENND4A IQSEC2 WDR27 DCLRE1B SIK3 EHD3 TTLL12 LINGO1 PLCB1 CD58 NLRC5 | 2.19e-03 | 1382 | 125 | 14 | EFO_0004833 |
| Disease | depressive symptom measurement | 2.31e-03 | 426 | 125 | 7 | EFO_0007006 | |
| Disease | Antibody Deficiency Syndrome | 2.32e-03 | 17 | 125 | 2 | C0003257 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 2.32e-03 | 17 | 125 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | cardiac troponin T measurement | 2.45e-03 | 219 | 125 | 5 | EFO_0005043 | |
| Disease | lysophosphatidylcholine 22:6 measurement | 2.61e-03 | 18 | 125 | 2 | EFO_0010365 | |
| Disease | Age-related macular degeneration | 2.61e-03 | 18 | 125 | 2 | cv:C0242383 | |
| Disease | cognitive function measurement | CACNA1C DENND4A RBL2 TRIOBP GRID2 ZDBF2 EXD3 TENM4 LINGO1 SPOCK3 CTNNA3 PKHD1 ZNF638 PLCB1 | 3.07e-03 | 1434 | 125 | 14 | EFO_0008354 |
| Disease | Colorectal Carcinoma | 3.07e-03 | 702 | 125 | 9 | C0009402 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 3.55e-03 | 21 | 125 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 3.63e-03 | 346 | 125 | 6 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | triacylglycerol 54:6 measurement | 3.89e-03 | 22 | 125 | 2 | EFO_0010424 | |
| Disease | monocyte count | SELP TBXAS1 MTMR12 DENND4A TRPM7 GON4L ITPK1 EHD3 TTLL12 PPIG PLCB1 NLRC5 C3 | 4.00e-03 | 1320 | 125 | 13 | EFO_0005091 |
| Disease | migraine disorder | 4.23e-03 | 357 | 125 | 6 | MONDO_0005277 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PFAPQLGDTQNCQLR | 31 | Q9UK28 | |
| RICEQAPQQALPQSF | 746 | Q9BXU7 | |
| IFICQASFQQAQPSP | 121 | O14734 | |
| LYNPIPVRQNCLTVN | 61 | O00555 | |
| PDLNDCVSINRAVPQ | 26 | Q52LR7 | |
| LVTQQFPCQNPLPVN | 26 | O14965 | |
| QDQAQAARLPPQDFL | 516 | Q07065 | |
| PIQSPQNRFCVLTLD | 176 | Q8WTX7 | |
| GQQTAQRAELQCPQP | 651 | P01024 | |
| INNRALFPCQEPPVA | 276 | Q8N6M6 | |
| QEAQQACRPHNLPVL | 101 | Q14129 | |
| ACRPHNLPVLQAAQQ | 106 | Q14129 | |
| NTNCNPALVLPSRQE | 146 | Q9H816 | |
| VQLARRQCTNPTPAN | 536 | Q8TE58 | |
| VANAFCSAAQLQPQP | 516 | Q9Y6R0 | |
| IQPATCNSRNQSPQL | 5371 | Q9HC84 | |
| LQENFCTRSIQIPAN | 1556 | Q7Z401 | |
| FDQLTQCLIQAPSNR | 366 | Q5U651 | |
| SQPLPKQEVLAQCFR | 1026 | Q9H2T7 | |
| ASPPIETDLQNQACQ | 1086 | Q5T481 | |
| RNNSPQELCTPQSVF | 96 | A6NCL2 | |
| PTPQIQQRFDELCSR | 41 | Q08999 | |
| PQPTQVQFVCDRQEA | 1041 | P51610 | |
| DNSASLRCENIQPNP | 401 | Q8TDR0 | |
| VPEARQCQPVLQGFS | 3721 | Q9NU22 | |
| IVFNQEGLNAIQPPC | 171 | Q13572 | |
| TAQICARPDPFQQAL | 641 | Q9H2X6 | |
| LPQKIQCTLSNPLFN | 181 | P19256 | |
| FQNSPPASVCLNDIQ | 416 | Q8TAT5 | |
| QAPQAEAPCLLRNSA | 686 | Q9C0I1 | |
| FVCSLPRNVEIPQLN | 721 | Q96T76 | |
| VCNPALVRQFRNPDT | 866 | Q5JU85 | |
| NSQPQLCEIPYRVSQ | 566 | Q99665 | |
| RCPFLVLSATINNPN | 891 | Q5H9U9 | |
| PVFCPNARQTLEVPQ | 836 | Q9BRR8 | |
| QTFPVPQNISQRCFR | 286 | O43424 | |
| TPQDINRPLNAAQCL | 406 | Q6KC79 | |
| NRCLQVLFPPAQIAQ | 511 | Q96MW5 | |
| QVRVTPACNTSLPAQ | 61 | Q9UBG0 | |
| RLNFNRQQPTCATPE | 386 | Q96FE5 | |
| LRNTNPNFVRCIIPN | 661 | P35579 | |
| RSPAEVNNNPCLENN | 2336 | P98164 | |
| DIRNATQFAPVCPQN | 106 | Q8N2Q7 | |
| TQFAPVCPQNIIDGR | 111 | Q8N2Q7 | |
| GNRVPLCINPQSAAF | 491 | Q9UBE8 | |
| PPLTQQQAAQKRTCD | 246 | Q76FK4 | |
| PALDVFQLRPACQQV | 741 | Q9BZ72 | |
| VARQFNLTPPICEQA | 201 | Q13303 | |
| SETQQQLCVQLEFPR | 1416 | Q86WI3 | |
| QLCVQLEFPRQEENP | 1421 | Q86WI3 | |
| QERVANQRIEFPCPA | 1276 | Q96RW7 | |
| QRPRCFFDIAINNQP | 6 | Q13427 | |
| TLQRAPQARPSAAQC | 6701 | Q5VST9 | |
| CPPAPNDNNTLAAQR | 336 | P20393 | |
| TQNPQCPIFRLGDIF | 221 | Q99572 | |
| DVLARQIANQCPDPS | 746 | Q9UI47 | |
| QEALVPAQPQLNVCN | 476 | P34059 | |
| NRAANPPVNIDADQL | 381 | P87889 | |
| NRAANPPVNIDADQL | 381 | Q9YNA8 | |
| NRAANPPVNIDADQL | 381 | P62683 | |
| NRAANPPVNIDADQL | 381 | P63145 | |
| NRAANPPVNIDADQL | 381 | Q7LDI9 | |
| NRAANPPVNIDADQL | 381 | P63130 | |
| NRAANPPVNIDADQL | 381 | P62685 | |
| NRAANPPVNIDADQL | 381 | P63126 | |
| NRAANPPVNIDADQL | 381 | P62684 | |
| FLQCAEQVQPPRSPA | 86 | Q9BSY4 | |
| PQASPQQVQRCVEIL | 266 | A1L0T0 | |
| QSPNGALLPFVNCRD | 2171 | Q13936 | |
| NVQPNLQSPILSAAC | 61 | A6NGG3 | |
| TPNNPSCNADLINRV | 691 | P54289 | |
| CVAEPRPNFNTPQAL | 616 | Q3T8J9 | |
| CNPNLNPEATTTRIF | 711 | Q3T8J9 | |
| QEAQQACRPHNLPVV | 101 | Q9BY27 | |
| ACRPHNLPVVQAAQQ | 106 | Q9BY27 | |
| LQCQDLPVPNEARVN | 446 | P16109 | |
| IEPPQCQFAQQHEQR | 216 | Q8N7U6 | |
| QNPESSSCRPLVNVA | 166 | Q3LI81 | |
| QQRLLQPDFQPVCAS | 246 | Q9UJW0 | |
| CRFADQTAVQLPPQR | 571 | Q8NEC7 | |
| FVCEAVQETPRSQPQ | 661 | Q96RY7 | |
| EQLLQQPSSPSCVRQ | 206 | O94829 | |
| FQCVQHIQPPNQEQR | 731 | O43933 | |
| PFDSRFPNQNQTRNC | 16 | P14854 | |
| VNNSRNNTPECLAPV | 256 | Q96FZ2 | |
| ERFNPPSNVTVRCNT | 216 | P15509 | |
| QVLLFQNCNLSSFPP | 281 | Q8WUT4 | |
| QSQNPSIPFADCLAQ | 86 | Q8WZA6 | |
| NAARPQCPVGFNTLA | 276 | Q96FA3 | |
| PNQRQNVCAENEGIP | 111 | Q93086 | |
| DNVVCSQPARNFSRP | 671 | Q86VP1 | |
| NLRANRIPQCPLEND | 231 | Q68CR1 | |
| QFPLDLAVQNVVCPV | 221 | Q6ZUK4 | |
| CRDIQPFSQDPTQLA | 91 | P52630 | |
| PSVFQCVPNLQRLNL | 271 | Q86VH5 | |
| CVDPPEFQGQNVRQV | 396 | Q9H3W5 | |
| VPPAINQFTQALDRQ | 76 | P62424 | |
| NCFINSSIPPALQID | 1081 | Q8NE09 | |
| CNNRLQQPAVLQPLA | 516 | Q92696 | |
| QRQEANAARPQCPVG | 321 | Q8N2H9 | |
| PIVNLQAFQRQPAAV | 286 | Q5VWT5 | |
| NQRLQCFGDVIIPNP | 406 | Q92786 | |
| TPDRLPCQQLLQQAQ | 1086 | Q9P2F8 | |
| PCQQLLQQAQAAIPR | 1091 | Q9P2F8 | |
| LPSRSAIFQQQPENC | 771 | Q9Y2K2 | |
| CPDFRQERQQLPGQS | 4021 | P08F94 | |
| RANPYIAPPQLQQCQ | 191 | Q9Y6Y8 | |
| LAQQSNSPFQVILCP | 196 | Q9UHV7 | |
| ENKINITCPNQVQPF | 686 | Q6P1J6 | |
| QQGEQQQIPDPCRLS | 1191 | Q7Z745 | |
| LQPFCTQDTRDRPFQ | 171 | Q8NFA2 | |
| AFLNRFVCAQLPNPV | 131 | Q9NZN3 | |
| PFSSCLREVENPQNQ | 231 | O43556 | |
| PIRATQQDNPRTCIQ | 806 | Q9H2D6 | |
| NRAANPPVNIDADQL | 381 | P63128 | |
| LPDRPQAQQLQSCQG | 176 | Q499Z3 | |
| DNCRLVPNPAQEDSN | 681 | P35443 | |
| PQVNINFPQLGLCRD | 81 | Q14508 | |
| RFQACPETQVPLQLE | 501 | P24557 | |
| FIQQRNVSCPQLEVP | 2541 | P04275 | |
| LQCQLSLPQAFPRRN | 151 | A6NJB7 | |
| FACPILRQQTSDSNP | 336 | Q96G75 | |
| NVCEERVVNNQPLPS | 346 | Q9NXZ1 | |
| QATEVRICPVEFNPN | 26 | Q9UI30 | |
| LPPSAATVNNRCFQQ | 236 | Q8TB22 | |
| FPRPNLACGVNVNDS | 116 | P47872 | |
| TNNRSNLVRPPVICN | 171 | Q9HCK1 | |
| VNFTSNIQPICIPQE | 176 | Q7Z5A4 | |
| NEIPSCDLSNFARPN | 1006 | Q6N022 | |
| LFPNQPQQPNSRCSV | 356 | Q9HCK4 | |
| CQAPTRPQALSTNLQ | 56 | Q6ZMU5 | |
| PQILEVNFNPDCERA | 601 | Q14166 | |
| LNNLCPRPEIDNIFS | 216 | Q9NQ66 | |
| QALSNCPPLTQFFLE | 161 | Q9Y2K6 | |
| RQQDPPCQTELSNIQ | 311 | Q9BQ16 | |
| QNNRLCLPRNELDNP | 486 | Q6XPS3 | |
| EINPAALVRAQQCPS | 386 | A2RRH5 | |
| PIAQNNAPSFCPLVV | 2066 | P01266 | |
| QCNIFGQDLPAVPQR | 1326 | Q96QT4 | |
| QNISASVPNPNVICN | 246 | Q14966 | |
| NPQQTRFPDFLDCLP | 351 | Q9GZV5 | |
| ENVLSPQQPSRFCSL | 896 | Q96L42 | |
| APALCPNAAIQQRLA | 251 | Q8N9H8 | |
| AQPRVATIQQCQSPT | 406 | Q86TC9 |